UCSF

A study is showing that it may be possible to predict the onset of epileptic seizures several days in advance. By analyzing data from a brain implant designed to monitor and prevent seizures, the research hopes to develop a seizure forecasting tool.

New research has shown how immune cells produced in the gut play a protective role during MS flare-ups. For the first time scientists have shown how these immune cells travel up to the brain and potentially help shift a disease flare-up into remission.

A new study is challenging popular dietary dogma by suggesting a common type of intermittent fasting does not work for weight loss. The clinical trial found the 16:8 method of eating no more effective for losing weight than eating throughout the day.

New research has screened thousands of ingredients previously thought to be inert that are added to common drugs. The findings reveal several dozen of these compounds may actually be biologically active and cause unintended physiological effects.

A comprehensive new study, led by scientists from UC San Francisco, is offering robust new insights into the way a ketogenic diet can influence the gut microbiome, and subsequently result in broader health benefits.

Some exciting advances are being made when it comes to blood-testing for Alzheimer's, with the latest example offering a way to spot a traditionally hard-to-detect protein called tau, which is considered a key biomarker of the disease.

A new study shows that disabling a single protein in human cells could render the cold virus ineffective.

Proteins are the workhorses of the cell, but nature sometimes has room for improvement. Now a team from the Institute for Protein Design and the University of California San Francisco has created a new artificial protein that acts like a switch, turning regular cells into “smart cells.”

Biologists often concern themselves with preserving cells. However, it is also advantageous to learn how to kill them, without having their contents exploding into neighboring tissue. That's exactly what bioengineers have done by linking a "suicide" enzyme with a light-sensitive molecule.

A new hope for MS treatment might be on the way. This week, the US Food and Drug Administration (FDA) has approved a new drug, called ocrelizumab, which fights MS by targeting the body’s B cells and is the first to have an effect on the more severe form of the disease.

Until now, blood cell production was ascribed solely to bone marrow, but studies on mice have found that the majority of the body’s platelets are produced in the lungs, as is a backup reservoir of blood stem cells that can step in when those in the bone marrow run dry.

Treatments for symptoms of spinal cord injuries may be a step closer, as researchers at UCSF have transplanted human neurons into mice with these injuries, and found that over time they made new connections in the spine, reducing chronic pain and helping the mice regain some bladder control.